CALOSYN PHARMA, INC.

CIK: 1429819•DE•Incorporated: 2007-09-21

Latest Reported Offering

$20,000
Target Amount
$1,235,000
Maximum Amount
2026-02-27
Deadline

Security Details

Type: Other
Price per share: $0.00
Price set by: N/A
Shares offered: 20,000+

Offering Costs

Cash commission: —
7 - 13 percent
Equity compensation: —
One percent (1%) of securities of the total amount of investments raised in the offering, along the same terms as investors.

Filing history

Form C family — 3 filings
FiledFormFile numberPortalWhat it statesWhat the filer said
2026-03-02C-U020-36429StartEngine Primary LLC$20K target, up to $1.2M · Convertible Note · closes 2026-02-27At the close of the offering, the issuer closed on $126,903.04 and 0 number of securities.
2025-12-19C/A020-36429StartEngine Primary LLC$20K target, up to $1.2M · Convertible Note · closes 2026-02-27Extending the Campaign End Date to February 27 2026
2025-09-30C020-36429StartEngine Primary LLC$20K target, up to $1.2M · Convertible Note · closes 2025-12-29—
Embarc dashboard

Form C prints a most-recent and a prior fiscal year side by side but never names them. The dashboard chains every filing into those years and plots them. EDGAR still has each Form C-AR; the dashboard lays every year they filed next to it.

  • Reported financials chained into fiscal years — revenue, income, assets, cash — not one filing at a time
  • A sparkline on each figure so the shape is visible before the numbers
  • A revenue series dated to the filings that reported it
  • The campaign as filed: target, ceiling, deadline, and the portal that ran it
  • Follow it, and see it change on your watchlist
Open in the dashboard

Company Information

Legal Status
Corporation
Jurisdiction
DE
Date of Incorporation
2007-09-21

Latest Metrics

Employees3
Total Assets$164,279
Cash on Hand$147,320
Revenues$0.00
Net Income-$637,680

Crowdfunding Portals

The intermediary named in this company’s Form C filings. Investments in a Regulation Crowdfunding offering can only be made through them.